Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 87

1.

NK Cells from RAG- or DCLRE1C-Deficient Patients Inhibit HCMV.

Wu Z, Subramanian N, Jacobsen EM, Laib Sampaio K, van der Merwe J, Hönig M, Mertens T.

Microorganisms. 2019 Nov 10;7(11). pii: E546. doi: 10.3390/microorganisms7110546.

2.

[Vaccination in Germany - Recommendations of STIKO].

Mertens T.

Dtsch Med Wochenschr. 2019 Feb;144(4):239-243. doi: 10.1055/a-0479-3890. Epub 2019 Feb 13. German.

PMID:
30759472
3.

Human Macrophages Escape Inhibition of Major Histocompatibility Complex-Dependent Antigen Presentation by Cytomegalovirus and Drive Proliferation and Activation of Memory CD4+ and CD8+ T Cells.

Frascaroli G, Lecher C, Varani S, Setz C, van der Merwe J, Brune W, Mertens T.

Front Immunol. 2018 May 25;9:1129. doi: 10.3389/fimmu.2018.01129. eCollection 2018.

4.

Classic paper: Are the chickenpox virus and the zoster virus identical?: HELMUT RUSKA.

Kruger DH, Mertens T.

Rev Med Virol. 2018 May;28(3):e1975. doi: 10.1002/rmv.1975. Epub 2018 Apr 6.

PMID:
29626377
5.

Varicella-zoster-virus vaccination in immunosuppressed children with rheumatic diseases using a pre-vaccination check list.

Speth F, Hinze CH, Andel S, Mertens T, Haas JP.

Pediatr Rheumatol Online J. 2018 Mar 2;16(1):15. doi: 10.1186/s12969-018-0231-3.

6.

Naïve T cells are activated by autologous HCMV-infected endothelial cells through NKG2D and can control HCMV transmission in vitro.

Subramanian N, Wu Z, Reister F, Sampaio KL, Frascaroli G, Cicin-Sain L, Mertens T.

J Gen Virol. 2017 Nov 21. doi: 10.1099/jgv.0.000976. [Epub ahead of print]

PMID:
29165229
7.

Use of Viral Load as a Surrogate Marker in Clinical Studies of Cytomegalovirus in Solid Organ Transplantation: A Systematic Review and Meta-analysis.

Natori Y, Alghamdi A, Tazari M, Miller V, Husain S, Komatsu T, Griffiths P, Ljungman P, Orchanian-Cheff A, Kumar D, Humar A; CMV Consensus Forum.

Clin Infect Dis. 2018 Feb 1;66(4):617-631. doi: 10.1093/cid/cix793.

PMID:
29020339
8.

Human Cytomegalovirus Particles Treated with Specific Antibodies Induce Intrinsic and Adaptive but Not Innate Immune Responses.

Wu Z, Qin R, Wang L, Bosso M, Scherer M, Stamminger T, Hotter D, Mertens T, Frascaroli G.

J Virol. 2017 Oct 27;91(22). pii: e00678-17. doi: 10.1128/JVI.00678-17. Print 2017 Nov 15.

9.

Peptide vaccination in the presence of adjuvants in patients after hematopoietic stem cell transplantation with CD4+ T cell reconstitution elicits consistent CD8+ T cell responses.

Schmitt M, Schmitt A, Wiesneth M, Hückelhoven A, Wu Z, Kuball J, Wang L, Schauwecker P, Hofmann S, Götz M, Michels B, Maccari B, Wuchter P, Eckstein V, Mertens T, Schnitzler P, Döhner H, Ho AD, Bunjes DW, Dreger P, Schrezenmeier H, Greiner J.

Theranostics. 2017 Apr 10;7(6):1705-1718. doi: 10.7150/thno.18301. eCollection 2017.

10.

Impfen bei Immundefizienz : Anwendungshinweise zu den von der Ständigen Impfkommission empfohlenen Impfungen(I) Grundlagenpapier.

Niehues T, Bogdan C, Hecht J, Mertens T, Wiese-Posselt M, Zepp F.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Jun;60(6):674-684. doi: 10.1007/s00103-017-2555-4. German. No abstract available.

PMID:
28466129
11.

Development of a high-throughput colorimetric Zika virus infection assay.

Müller JA, Harms M, Schubert A, Mayer B, Jansen S, Herbeuval JP, Michel D, Mertens T, Vapalahti O, Schmidt-Chanasit J, Münch J.

Med Microbiol Immunol. 2017 Apr;206(2):175-185. doi: 10.1007/s00430-017-0493-2. Epub 2017 Feb 7.

12.

Hintergrundpapier der STIKO: Evaluation der bestehenden Influenzaimpfempfehlung für Indikationsgruppen und für Senioren (Standardimpfung ab 60 Jahren).

Remschmidt C, Harder T, Wichmann O, Garbe E, Ledig T, Terhardt M, Wicker S, Zepp F, Mertens T.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016 Dec;59(12):1606-1622. German. No abstract available.

PMID:
27815578
13.

Phenotypic characterization of human cytomegalovirus strains in cell cultures based on their transmission kinetics.

Subramanian N, Wu Z, Mertens TM.

J Gen Virol. 2016 Sep;97(9):2376-2386. doi: 10.1099/jgv.0.000543. Epub 2016 Jul 12.

PMID:
27405754
14.

Inactivation and Environmental Stability of Zika Virus.

Müller JA, Harms M, Schubert A, Jansen S, Michel D, Mertens T, Schmidt-Chanasit J, Münch J.

Emerg Infect Dis. 2016 Sep;22(9):1685-7. doi: 10.3201/eid2209.160664. Epub 2016 Sep 15. No abstract available.

15.

Megapinocytosis: a novel endocytic pathway.

Bauer A, Subramanian N, Villinger C, Frascaroli G, Mertens T, Walther P.

Histochem Cell Biol. 2016 Jun;145(6):617-27. doi: 10.1007/s00418-015-1395-2. Epub 2016 Jan 6.

PMID:
26733077
16.

3D Analysis of HCMV Induced-Nuclear Membrane Structures by FIB/SEM Tomography: Insight into an Unprecedented Membrane Morphology.

Villinger C, Neusser G, Kranz C, Walther P, Mertens T.

Viruses. 2015 Nov 4;7(11):5686-704. doi: 10.3390/v7112900.

17.

Human Cytomegalovirus pUL47 Modulates Tegumentation and Capsid Accumulation at the Viral Assembly Complex.

Cappadona I, Villinger C, Schutzius G, Mertens T, von Einem J.

J Virol. 2015 Jul;89(14):7314-28. doi: 10.1128/JVI.00603-15. Epub 2015 May 6.

18.

Interleukin-2 from Adaptive T Cells Enhances Natural Killer Cell Activity against Human Cytomegalovirus-Infected Macrophages.

Wu Z, Frascaroli G, Bayer C, Schmal T, Mertens T.

J Virol. 2015 Jun;89(12):6435-41. doi: 10.1128/JVI.00435-15. Epub 2015 Apr 8.

19.

Natural killer cells can inhibit the transmission of human cytomegalovirus in cell culture by using mechanisms from innate and adaptive immune responses.

Wu Z, Sinzger C, Reichel JJ, Just M, Mertens T.

J Virol. 2015 Mar;89(5):2906-17. doi: 10.1128/JVI.03489-14. Epub 2014 Dec 24.

20.

Human cytomegalovirus infection impairs endothelial cell chemotaxis by disturbing VEGF signalling and actin polymerization.

Reinhardt B, Godfrey R, Fellbrich G, Frank H, Lüske A, Olieslagers S, Mertens T, Waltenberger J.

Cardiovasc Res. 2014 Nov 1;104(2):315-25. doi: 10.1093/cvr/cvu204. Epub 2014 Sep 16.

PMID:
25228663

Supplemental Content

Loading ...
Support Center